Abstract
5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.
O Massot, J C Rousselle, M P Fillion, B Grimaldi, I Cloëz-Tayarani, A Fugelli, N Prudhomme, L Seguin, B Rousseau, M Plantefol, R Hen and G Fillion
Molecular Pharmacology October 1996, 50 (4) 752-762;
O Massot
J C Rousselle
M P Fillion
B Grimaldi
I Cloëz-Tayarani
A Fugelli
N Prudhomme
L Seguin
B Rousseau
M Plantefol
R Hen
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Abstract
5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.
O Massot, J C Rousselle, M P Fillion, B Grimaldi, I Cloëz-Tayarani, A Fugelli, N Prudhomme, L Seguin, B Rousseau, M Plantefol, R Hen and G Fillion
Molecular Pharmacology October 1, 1996, 50 (4) 752-762;
Abstract
5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine1B/1D receptors.
O Massot, J C Rousselle, M P Fillion, B Grimaldi, I Cloëz-Tayarani, A Fugelli, N Prudhomme, L Seguin, B Rousseau, M Plantefol, R Hen and G Fillion
Molecular Pharmacology October 1, 1996, 50 (4) 752-762;
Jump to section
Related Articles
Cited By...
Similar Articles
Advertisement